Endostar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Antiangiogenesis plays a key role in the treatment of non‐small lung cancer (NSCLC). We observed the cavitation of lesions in…
Angiogenesis plays an essential role in the growth and metastasis of a number of tumors. Anti-angiogenic drugs are able to…
Abstract
The present study was designed to investigate the synergetic effect of Endostar combined with an angiopoietin-2 specific…
背景与目的 血管内皮抑素可以抑制肿瘤新生血管的生成，但对肿瘤微淋巴管的形成与发展是否存在抑制效应引起我们关注。本研究旨在探讨重组人血管内皮抑素（recombinant human endostatin injection…
Anti-angiogenic agents have played crucial roles in the treatment of ovarian cancer in recent years, but potential benefits of…
Standard chemotherapy for advanced NSCLC has reached a therapeutic plateau. More effective strategies must be explored. The…
Combination treatment with endostar, a novel modified endostatin, and cytotoxic chemotherapies showed a survival benefit in…
OBJECTIVE
To analyze the efficacy and quality of life and safety for paclitaxel and carboplatin (TC) and TC combined with…
PurposeAntiangiogenic drugs inhibit tumor growth by decreasing blood supply and causing transient “normalization” of the tumor…
PURPOSE
Endostar is a proteolytic fragment of collagen XVIII that has been shown to have antitumor activity, with a favorable…